Current role
Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present
Todd Franklin Watanabe
Board Member
Arcutis Biotherapeutics, Inc. (ARQT)Equibles does not estimate personal net worth.
Get an email with a short summary when Arcutis Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARQT alertsAbout Todd Franklin Watanabe
Todd Franklin Watanabe is recorded as Board Member at Arcutis Biotherapeutics, Inc. (ARQT) since January 1, 2017 and CEO at Arcutis Biotherapeutics, Inc. (ARQT). The newest filing on record that lists Todd Franklin Watanabe as CEO and Board Member at Arcutis Biotherapeutics, Inc. (ARQT) is dated April 21, 2026. The proxy statement of Arcutis Biotherapeutics, Inc. reports total compensation of $7,223,065 for Todd Franklin Watanabe in fiscal 2025, including a base salary of $713,333. Disclosed compensation is on record for 7 fiscal years. Arcutis Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcutis Biotherapeutics, Inc. includes Latha Vairavan (CFO), Masaru Matsuda (General Counsel), David Topper (Chief Accounting Officer) and 7 others.
Affiliation history
-
Current
2017-01-01–present
Last confirmed April 21, 2026
-
Current
Start not stated–present
Last confirmed April 21, 2026
Company network
Leadership on record at Arcutis Biotherapeutics, Inc.
- Latha Vairavan CFO
- Masaru Matsuda General Counsel
- David Topper Chief Accounting Officer
- Scott Burrows Chief Accounting Officer
- Amit D. Munshi Board Member
- Chris Peetz Board Member
- Christopher Peetz Board Member
- Halley E. Gilbert Board Member
- Howard G. Welgus Board Member
- Howard Welgus, M.D., FAAD Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $713,333 | $7,223,065 |
| 2024 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $660,867 | $3,689,491 |
| 2023 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $633,500 | $4,935,266 |
| 2022 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $590,000 | $4,581,555 |
| 2021 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $525,000 | $4,284,123 |
| 2020 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $441,667 | $2,750,883 |
| 2019 | Arcutis Biotherapeutics, Inc. (ARQT) | President and Chief Executive Officer | $390,000 | $1,140,296 |
Recent activity
No call appearances or filed executive changes recorded yet.